The idea of reducing CLDN2 expression in cells by mimicking the short peptide of CLDN2’s second extracellular loop (ECL2) to improve tumor cell sensitivity to chemotherapy drugs provides us with new inspiration. Here, CLDN2 is linked to neoplasm.